349 related articles for article (PubMed ID: 7952605)
1. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users.
Caiaffa WT; Vlahov D; Graham NM; Astemborski J; Solomon L; Nelson KE; Muñoz A
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1493-8. PubMed ID: 7952605
[TBL] [Abstract][Full Text] [Related]
2. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group.
Hirschtick RE; Glassroth J; Jordan MC; Wilcosky TC; Wallace JM; Kvale PA; Markowitz N; Rosen MJ; Mangura BT; Hopewell PC
N Engl J Med; 1995 Sep; 333(13):845-51. PubMed ID: 7651475
[TBL] [Abstract][Full Text] [Related]
3. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group.
Wallace JM; Hansen NI; Lavange L; Glassroth J; Browdy BL; Rosen MJ; Kvale PA; Mangura BT; Reichman LB; Hopewell PC
Am J Respir Crit Care Med; 1997 Jan; 155(1):72-80. PubMed ID: 9001292
[TBL] [Abstract][Full Text] [Related]
4. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.
Phair J; Muñoz A; Detels R; Kaslow R; Rinaldo C; Saah A
N Engl J Med; 1990 Jan; 322(3):161-5. PubMed ID: 1967190
[TBL] [Abstract][Full Text] [Related]
5. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
8. Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection.
McCoy CB; Lai S; Metsch LR; Messiah SE; Zhao W
Ann Epidemiol; 2004 Sep; 14(8):535-42. PubMed ID: 15350952
[TBL] [Abstract][Full Text] [Related]
9. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
10. Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy.
Miguez-Burbano MJ; Burbano X; Ashkin D; Pitchenik A; Allan R; Pineda L; Rodriguez N; Shor-Posner G
Addict Biol; 2003 Mar; 8(1):39-43. PubMed ID: 12745414
[TBL] [Abstract][Full Text] [Related]
11. Respiratory illness in persons with human immunodeficiency virus infection. The Pulmonary Complications of HIV Infection Study Group.
Wallace JM; Rao AV; Glassroth J; Hansen NI; Rosen MJ; Arakaki C; Kvale PA; Reichman LB; Hopewell PC
Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1523-9. PubMed ID: 8256894
[TBL] [Abstract][Full Text] [Related]
12. The association between cigarette smoking and selected HIV-related medical conditions.
Conley LJ; Bush TJ; Buchbinder SP; Penley KA; Judson FN; Holmberg SD
AIDS; 1996 Sep; 10(10):1121-6. PubMed ID: 8874629
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M
CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423
[TBL] [Abstract][Full Text] [Related]
14. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
Sogaard OS; Lohse N; Gerstoft J; Kronborg G; Ostergaard L; Pedersen C; Pedersen G; Sørensen HT; Obel N
Clin Infect Dis; 2008 Nov; 47(10):1345-53. PubMed ID: 18834317
[TBL] [Abstract][Full Text] [Related]
15. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
[TBL] [Abstract][Full Text] [Related]
16. The relationship of candidiasis to linear gingival erythema in HIV-infected homosexual men and parenteral drug users.
Grbic JT; Mitchell-Lewis DA; Fine JB; Phelan JA; Bucklan RS; Zambon JJ; Lamster IB
J Periodontol; 1995 Jan; 66(1):30-7. PubMed ID: 7891247
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD;
N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837
[TBL] [Abstract][Full Text] [Related]
18. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.
Thea DM; Lambert G; Weedon J; Matheson PB; Abrams EJ; Bamji M; Straus WL; Thomas PA; Krasinski K; Heagarty M
Pediatrics; 1996 Jan; 97(1):59-64. PubMed ID: 8545225
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)-positive and HIV-negative immunocompromised patients.
Nüesch R; Bellini C; Zimmerli W
Clin Infect Dis; 1999 Dec; 29(6):1519-23. PubMed ID: 10585806
[TBL] [Abstract][Full Text] [Related]
20. Crack cocaine: a risk factor for human immunodeficiency virus infection type 1 among inner-city parturients.
Lindsay MK; Peterson HB; Boring J; Gramling J; Willis S; Klein L
Obstet Gynecol; 1992 Dec; 80(6):981-4. PubMed ID: 1448268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
